Українська English

ISSN 2522-9028 (Print)
ISSN 2522-9036 (Online)
DOI: https://doi.org/10.15407/fz

Fiziologichnyi Zhurnal

is a scientific journal issued by the

Bogomoletz Institute of Physiology
National Academy of Sciences of Ukraine

Editor-in-chief: V.F. Sagach

The journal was founded in 1955 as
1955 – 1977 "Fiziolohichnyi zhurnal" (ISSN 0015 – 3311)
1978 – 1993 "Fiziologicheskii zhurnal" (ISSN 0201 – 8489)
1994 – 2016 "Fiziolohichnyi zhurnal" (ISSN 0201 – 8489)
2017 – "Fiziolohichnyi zhurnal" (ISSN 2522-9028)

Fiziol. Zh. 2017; 63(6): 3-8

ENDOTHELIAL MONOCYTE-ACTIVATING POLYPEPTIDE-II IMPROVES DIASTOLIC HEART FUNCTION AND VASCULAR RELAXATION IN STREPTOZOTOCIN-INDUCED EXPERIMENTAL DIABETES

N.A. Dorofeyeva1, G.G. Vorobyov1, I.Y. Cherepaha1, A.I. Kornelyuk2, V.F. Sagach1

  1. Bogomoletz Institute of Physiology, National Academy of Sciences of Ukraine, Kyiv
  2. The Institute of Molecular Biology and Genetics, National Academy of Sciences of Ukraine, Kyiv
DOI: https://doi.org/10.15407/fz63.06.003


Abstract

To investigate the effects of EMAP II on cardiac function and endothelium-dependent relaxation of smooth muscles of the aorta in diabetes mellitus, studies were conducted on 6 monthsold male streptozotocin-induced diabetic rats and control rats. In experiments in vivo, we have shown that EMAP II improves diastolic heart function in streptozotocin-induced diabetic rats. The End-diastolic pressure in streptozotocin-induced diabetic rats was decreased by 25,4% (P<0,05), the end-diastolic myocardial stiffness decreased by 25,5% (P<0,05). After EMAP II the end-systolic pressure decreased by 13,8% and the arterial stiffness decreased by 26,3% (P<0,05). In vitro experiments on II promotes the improvement and restoration of endotheliumdependent relaxation in streptozotocin-induced diabetic rats. Inhibition of NOS activity with L-NAME abolished EMAP II-mediated vasodilatation in the endothelium-intact aorta that indicates the NOS-dependent mechanism of action of EMAP II. Thus, EMAP II had a positive effect on the heart and vessels of rats with streptozotocin-induced diabetes, improving diastolic heart function and vasorelaxation in diabetes.

Keywords: Endothelial monocyte-activating polypeptide II (EMAP II); diabetes; endothelium-dependent relaxation of the aorta; heart

Full text: (PDF, in Ukrainian)

References

  1. McVeigh GE, Gibson W, Hamilton PK. Cardiovascular risk in the young type 1 diabetes population with a low 10‐year, but high lifetime risk of cardiovascular disease. Diabet, Obesit and Metabol. 2013 Mar 1;15(3):198-203. CrossRef PubMed
    2.  
  2. Slim IB. Cardiovascular risk in type 1 diabetes mellitus. Ind J of Endocrin and metabol. 2013 Oct;17(Suppl1):S7.
    3.  
  3. Bertoluci MC, Cé GV, da Silva AM, Wainstein MV, Boff W, Pu-ales M. Endothelial dysfunction as a predictor of cardiovascular disease in type 1 diabetes. World J Diabet. 2015 Jun 10;6(5):679. CrossRef PubMed PubMedCentral
    4.  
  4. Tabit CE, Chung WB, Hamburg NM, Vita JA. Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications. Endocr and Metabol Disord. 2010 Mar 1;11(1):61-74. CrossRef PubMed PubMedCentral
    5.  
  5. Bondarenko OH, Galstyan GR, Antsiferov MB, Kuznetsova TV, Kobylyansky AG. The biological role of nitric oxide in diabetes mellitus. Diabet. 2002; 2: 56 -63.
    6.  
  6. Sahach VF, Tkachenko MM, Prysiazhna OD, Kotsiuruba AV, Mehed OF. Changes in vasodilator responses of vascular smooth muscles and nitric oxide system in experimental diabetes mellitus. Fiziol Zh. 1994. 2002 Dec;49(4):24-32. [Ukrainian].
    7.  
  7. Prysyazhna OD, Sagach VF, Kotsyuruba AV, Tkachenko MN. Endothelium-Dependent Stretch-Induced Contractile Responses of Vascular Smooth Muscles in Experimental Diabetes Mellitus, and the Nitric Oxide System. Neurophys. 2003 May 1;35(3):339-42. CrossRef  
  8. Tron'ko ND, Belchin YB, Sokolova LK. The role of endothelial dysfunction in the development of diabetic cardiomyopathy in patients with type 1 diabetes mellitus. Reports of the Nat Acad of Scienc Ukr. 2013 (11): 182-8.
    9.  
  9. Dorofeyeva NA, Kotsuruba AV, Mogilnitskaya LA, Malyna AE, Kornelyuk AI, Sagach VF. Endothelial monocyteactivating factor II cancels oxidative stress,constitutive NOS uncoupling and induced violations of cardiac hemodynamica in hypertension (part II). Fiziol Zh. 1994. 2014;61(3):11-8. [Ukrainian].
    10.  
  10. Salvemini D, Kim SF, Mollace V. Reciprocal regulation of the nitric oxide and cyclooxygenase pathway in pathophysiology: relevance and clinical implications. Am J Physiol-Regul Integr Comp Physiol. 2013 Apr 1;304(7):R473-87. CrossRef PubMed PubMedCentral
    11.  
  11. Mogylnytska LA, Dorofeyeva NA, Malyna AE, Kornelyuk AI, Sagach VF. Endothelial monocyte-activating polypeptide- II: properties, functions, and pathogenetic significance. Inter. J Physiol and Pathophysiol. 2016;7(2):179-191.
    12.  
  12. Tsai BM, Wang M, Clauss M, Sun P, Meldrum DR. Endothelial monocyte-activating polypeptide II causes NOSdependent pulmonary artery vasodilation: a novel effect for a proinflammatory cytokine. Am J Physiol-Regul Integr Comp Physiol. 2004;287(4):R767-71. CrossRef PubMed
    13.  
  13. Dubrovsky AL, Brown D, Kornelyuk AI, Murray DK, Matsuka GC. Bacterial expression of full-length and truncated forms of the cytokine EMAP-2 and the cytokine-like domain of mammalian tyrosyl-tRNA synthetase. Biopolym and Cell. 2000; 16 (3): 229-35. CrossRef  
  14. Bertoluci MC, Cé GV, da Silva AM, Wainstein MV, Boff W, Pu-ales M. Endothelial dysfunction as a predictor of cardiovascular disease in type 1 diabetes. World J of Diabet. 2015 Jun 10;6(5):679. CrossRef PubMed PubMedCentral
    15.  
  15. Lin SJ, Hong CY, Chang MS, Chiang BN, Chien S. Increased aortic endothelial death and enhanced transendothelial macromolecular transport in streptozotocindiabetic rats.Diabetologia 1993; 36: 926-30. CrossRef PubMed
    16.  
  16. Hadcock S, Richardson M, Winocour PD, Hatton MW. Intimal alterations in rabbit aortas during the first 6 months of alloxaninduced diabetes. Arterioscler Thromb 1991; 11: 517-29. CrossRef PubMed
    17.  
  17. Kojda G, Harrison D. Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure. Cardiovasc Res. 1999;43:562-71. CrossRef  
  18. Mahmud FH, Earing MG, Lee RA, Lteif AN, Driscoll DJ, Lerman A. Altered endothelial function in asymptomatic male adolescents with type 1 diabetes. Congenit Heart Dis. 2006;1:98–103. CrossRef PubMed
    19.  
  19. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol. 1996;271:C1424-C37. CrossRef PubMed
    20.  
  20. Yuan C, Yan L, Solanki P, Vatner SF, Vatner DE, Schwarz MA. Blockade of EMAP II protects cardiac function after chronic myocardial infarction by inducing angiogenesis.J Mol Cell Cardiol. 2015;79:224-31. CrossRef PubMed PubMedCentral
    21.  
  21. Tsai BM, Wang M, Clauss M, Sun P, Meldrum DR. Endothelial monocyte-activating polypeptide II causes NOSdependent pulmonary artery vasodilation: a novel effect for a proinflammatory cytokine. Am J Physiol-Regul Integr Comp Physiol. 2004;287(4):R767-71. CrossRef PubMed
    22.  
  22. Adly, A. A., Ismail, E. A., Tawfik, L. M., Ebeid, F. S., & Hassan, A. A. Endothelial monocyte activating polypeptide II in children and adolescents with type 1 diabetes mellitus: Relation to micro-vascular complications. Cytokine 2015; 76(2): 156-62. CrossRef PubMed 
© National Academy of Sciences of Ukraine, Bogomoletz Institute of Physiology, 2014-2025.